LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
Top Sells
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.02B |
| 2 |
iShares MSCI EAFE Growth ETF
EFG
|
+$340M |
| 3 |
iShares Core S&P US Growth ETF
IUSG
|
+$282M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$232M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$197M |
Sector Composition
| 1 | Technology | 7.42% |
| 2 | Financials | 3.81% |
| 3 | Healthcare | 2.68% |
| 4 | Consumer Discretionary | 2.67% |
| 5 | Industrials | 2.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5076
CytomX Therapeutics
CTMX
$341M
| $26.9K | ﹤0.01% |
42,315
| – | – |
|
5077
MacroGenics
MGNX
$109M
| $26.9K | ﹤0.01% |
21,158
| – | – |
|
5078
Tiziana Life Sciences
TLSA
$203M
| $26.6K | ﹤0.01% |
24,622
+10,000
| +68% | +$10.8K |
|
5079
Precigen
PGEN
$1.22B
| $26.5K | ﹤0.01% |
17,766
-19,856
| -53% | -$29.6K |
|
5080
Barnwell Industries
BRN
$11.6M
| $26.2K | ﹤0.01% |
16,198
+2,000
| +14% | +$3.24K |
|
|
BLDP
5081
Ballard Power Systems
BLDP
$580M
| $25.8K | ﹤0.01% |
23,438
-5,403
| -19% | -$5.94K |
|
5082
iQIYI
IQ
$2.5B
| $25.5K | ﹤0.01% |
11,269
-430
| -4% | -$972 |
|
5083
Annexon
ANNX
$252M
| $24.9K | ﹤0.01% |
+12,926
| New | +$24.9K |
|
|
VXRT
5084
DELISTED
Vaxart
VXRT
| $24.8K | ﹤0.01% |
60,955
+32,603
| +115% | +$13.3K |
|
5085
ATAI Life Sciences
ATAI
$1.01B
| $24.8K | ﹤0.01% |
18,225
+1,184
| +7% | +$1.61K |
|
5086
United States Antimony
UAMY
$586M
| $24.4K | ﹤0.01% |
11,100
-3,800
| -26% | -$8.36K |
|
5087
Quantum-Si Incorporated
QSI
$227M
| $24.1K | ﹤0.01% |
+20,112
| New | +$24.1K |
|
|
EQC
5088
DELISTED
Equity Commonwealth
EQC
| $24K | ﹤0.01% |
14,934
-7,093
| -32% | -$11.4K |
|
5089
FiscalNote
NOTE
$73M
| $23.7K | ﹤0.01% |
2,446
-6,250
| -72% | -$60.6K |
|
5090
Curis
CRIS
$22.4M
| $22.3K | ﹤0.01% |
10,599
-48
| -0.5% | -$101 |
|
5091
Paramount Gold Nevada
PZG
$73.6M
| $22.2K | ﹤0.01% |
60,125
+28,850
| +92% | +$10.7K |
|
5092
IceCure Medical
ICCM
$68.7M
| $22.2K | ﹤0.01% |
+18,875
| New | +$22.2K |
|
5093
CareCloud
CCLD
$148M
| $21.5K | ﹤0.01% |
+15,463
| New | +$21.5K |
|
5094
Stereotaxis
STXS
$256M
| $21.4K | ﹤0.01% |
12,150
+400
| +3% | +$704 |
|
|
ICAD
5095
DELISTED
iCAD Inc
ICAD
| $21.1K | ﹤0.01% |
+10,265
| New | +$21.1K |
|
5096
TRX Gold Corp
TRX
$127M
| $21K | ﹤0.01% |
67,532
+5,475
| +9% | +$1.7K |
|
5097
Ventyx Biosciences
VTYX
$169M
| $20.7K | ﹤0.01% |
18,029
+7,000
| +63% | +$8.05K |
|
5098
DHI Group
DHX
$143M
| $20.3K | ﹤0.01% |
14,605
| – | – |
|
5099
Inovio Pharmaceuticals
INO
$140M
| $19.9K | ﹤0.01% |
+12,197
| New | +$19.9K |
|
5100
Hyliion Holdings
HYLN
$288M
| $19.6K | ﹤0.01% |
+14,008
| New | +$19.6K |
|